Alla Katsnelson writes at Technology Review in RNA-Loaded Nanoparticles Fight Cancer that research just posted in Nature magazine shows early clinical success in targeting cancer cells and silencing target genes, so-called "gene silencing", via RNA Interference (RNAi), as Katsnelson writes:
"a powerful approach to creating new and potent medicines. "
